Provided by Tiger Fintech (Singapore) Pte. Ltd.

GH Research PLC

10.70
+0.72007.21%
Post-market: 10.48-0.2200-2.06%16:36 EDT
Volume:72.07K
Turnover:750.57K
Market Cap:663.70M
PE:-13.59
High:10.72
Open:10.06
Low:9.52
Close:9.98
Loading ...

GH Research Is Maintained at Buy by Guggenheim

Dow Jones
·
10 May

GH Research Price Target Maintained With a $40.00/Share by HC Wainwright & Co.

Dow Jones
·
09 May

GH Research Plc : Guggenheim Cuts Target Price to $29 From $32

THOMSON REUTERS
·
09 May

GH Research Q1 EPS $(0.19) Beats $(0.39) Estimate

Benzinga
·
08 May

GH Research Plc Qtrly Net Loss $0.19 per Share

THOMSON REUTERS
·
08 May

H.C. Wainwright Remains a Buy on GH Research (GHRS)

TIPRANKS
·
01 May

Psychedelic: Clearmind completes clinical site initiations for AUD trial

TipRanks
·
25 Apr

Psychedelic: Exclusive talk with biotech company Clearmind Medicine

TipRanks
·
22 Mar

Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial

TipRanks
·
14 Mar

Guggenheim starts GH Research at Buy, sees long-term upside potential

TipRanks
·
14 Mar

GH Research Initiated at Buy by Guggenheim

Dow Jones
·
13 Mar

Guggenheim Initiates GH Research at Buy With $32 Price Target

MT Newswires Live
·
13 Mar

GH Research Initiated at Outperform by RBC Capital

Dow Jones
·
08 Mar

RBC Initiates GH Research at Outperform, Speculative Risk With $31 Price Target

MT Newswires Live
·
07 Mar

Why GH Research PLC (GHRS) is Skyrocketing So Far in 2025

Insider Monkey
·
04 Mar

GH Research PLC (GHRS): Among the Best Psychedelic Stocks to Buy in 2025

Insider Monkey
·
02 Mar

Analysts Are Bullish on Top Healthcare Stocks: GH Research (GHRS), Cullinan Management (CGEM)

TIPRANKS
·
28 Feb

GH Research Is Maintained at Buy by Stifel

Dow Jones
·
27 Feb

GH Research Plc Files for Mixed Shelf of up to $400 Mln - SEC Filing

THOMSON REUTERS
·
27 Feb

GH Research 2024 GAAP EPS $(0.75), Down From $(0.68) YoY

Benzinga
·
27 Feb